Key stats
About Global X Genomics & Biotechnology UCITS ETF
Home page
Inception date
Nov 2, 2021
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
Carne Global Fund Managers (Ireland) Ltd.
ISIN
IE00BM8R0N95
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Stocks99.88%
Health Technology87.64%
Health Services12.24%
Bonds, Cash & Other0.12%
Cash0.12%
Stock breakdown by region
North America79.66%
Europe16.43%
Asia3.91%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
GNOG invests in stocks. The fund's major sectors are Health Technology, with 87.64% stocks, and Health Services, with 12.24% of the basket. The assets are mostly located in the North America region.
GNOG top holdings are Alnylam Pharmaceuticals, Inc and Illumina, Inc., occupying 5.20% and 4.77% of the portfolio correspondingly.
GNOG assets under management is 6.40 M GBP. It's risen 12.33% over the last month.
GNOG fund flows account for 3.04 M GBP (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, GNOG doesn't pay dividends to its holders.
GNOG shares are issued by Mirae Asset Global Investments Co., Ltd. under the brand Global X. The ETF was launched on Nov 2, 2021, and its management style is Passive.
GNOG expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
GNOG follows the Solactive Genomics v2 Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
GNOG invests in stocks.
GNOG price has risen by 6.14% over the last month, and its yearly performance shows a −26.69% decrease. See more dynamics on GNOG price chart.
NAV returns, another gauge of an ETF dynamics, showed a −10.13% decrease in three-month performance and has decreased by −24.05% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −10.13% decrease in three-month performance and has decreased by −24.05% in a year.
GNOG trades at a premium (0.04%) meaning the ETF is trading at a higher price than the calculated NAV.